GWG Announces Acquisition of Mortality Predictive Technology

MINNEAPOLIS, Nov. 03, 2016 (GLOBE NEWSWIRE) — GWG Holdings, Inc. (Nasdaq:GWGH), a financial services company engaged in the life insurance secondary market, today announced that it exercised its option to secure the exclusive license for the “DNA Methylation Based Predictor of Mortality” technology from the University of California, Los Angeles (UCLA).  The technology was discovered by Dr. Steve Horvath and is featured in the September 2016 edition of “Aging”.

In 2013, Dr. Horvath reported that human cells have a mechanism that records biological aging progression based on DNA methylation that is independent from chronological aging progression. In 2016, Dr. Horvath discovered a specifi…